DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time ... If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your ...

New York, New York-- (Newsfile Corp. - September 22, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, ...

Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...

Shares of DexCom Inc. DXCM slid 2.07% to $70.43 Friday, on what proved to be an all-around mixed trading session for the ...

Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

The blood glucose monitoring devices market has witnessed significant advancements and growth, driven by the increasing ...

DexCom Inc. closed $73.45 below its 52-week high ($142.00), which the company reached on March 26th.

Report Ocean has released a new report on the Digital Diabetes Management market, offering a comprehensive analysis of various factors, including market restraints, drivers, and opportunities. The ...

The device, called Lingo, will compete with a rival from DexCom (DXCM.O), opens new tab, launched last week, and will be available for adults who are not on insulin. Continuous glucose monitors ...